Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension

Article Type
Changed
Wed, 12/12/2018 - 09:35
Display Headline
Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension
Article PDF
Author and Disclosure Information

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Alejandro C. Arroliga, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Omar A. Minai, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: Omar A. Minai, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Dr. Minai has indicated that he has been a consultant to Actelion Pharmaceuticals.

Drs. Gildea and Arroliga have indicated that they have no commercial affiliations or interests that pose a potential conflict of interest with this article.

Publications
Page Number
S18-S27
Author and Disclosure Information

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Alejandro C. Arroliga, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Omar A. Minai, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: Omar A. Minai, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Dr. Minai has indicated that he has been a consultant to Actelion Pharmaceuticals.

Drs. Gildea and Arroliga have indicated that they have no commercial affiliations or interests that pose a potential conflict of interest with this article.

Author and Disclosure Information

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Alejandro C. Arroliga, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Omar A. Minai, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: Omar A. Minai, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Dr. Minai has indicated that he has been a consultant to Actelion Pharmaceuticals.

Drs. Gildea and Arroliga have indicated that they have no commercial affiliations or interests that pose a potential conflict of interest with this article.

Article PDF
Article PDF
Related Articles
Page Number
S18-S27
Page Number
S18-S27
Publications
Publications
Article Type
Display Headline
Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension
Display Headline
Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension
Citation Override
Cleveland Clinic Journal of Medicine 2003 April;70(suppl 1):S18-S27
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes

Article Type
Changed
Mon, 12/17/2018 - 08:12
Display Headline
Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes
Article PDF
Author and Disclosure Information

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Issue
Cleveland Clinic Journal of Medicine - 69(12)
Publications
Topics
Page Number
928-929, 933, 936, 939, 943-946
Sections
Author and Disclosure Information

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Author and Disclosure Information

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Page Number
928-929, 933, 936, 939, 943-946
Page Number
928-929, 933, 936, 939, 943-946
Publications
Publications
Topics
Article Type
Display Headline
Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes
Display Headline
Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media